Adrenocortical suppression with topical flumethasone.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000309:Adrenal Insufficiency / Q000139:chemically induced*; D000328:Adult; D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008297:Male; D008797:Metyrapone; D008875:Middle Aged; D009779:Occlusive Dressings; D010912:Pituitary-Adrenal Function Tests; D012869:Skin Absorption
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D005938:Glucocorticoids; D006854:Hydrocortisone; D008797:Metyrapone